Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial
| Autor: | von Minckwitz, Gunter *, Colleoni, Marco, Kolberg, Hans-Christian, Morales, Serafin, Santi, Patricia, Tomasevic, Zorica, Zhang, Nan, Hanes, Vladimir |
|---|---|
| Zdroj: | In The Lancet Oncology July 2018 19(7):987-998 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|